Latest filing published 14 Nov 2022 for CRESCENT BIOPHARMA, INC., €32k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -18.2%Entry US$170.00 · Close at T+365 US$139.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Harout Semerjian: trading record in brief
Harout Semerjian discloses dealings in 2 companies, chiefly Crescent Biopharma, Inc. and Immunomedics Inc. Between 16 April 2020 and 11 November 2022, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €32k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. So far in 2022, the count stands at 1 purchase and no sales.
The latest filing, published on 14 November 2022, reports an open-market purchase of €32k in Crescent Biopharma, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Harout Semerjian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$1.29100.0% of flowCommon StockSEC:0001209191-22-056581:0Canonical exit: 9 Feb 2023 (T+90)
- 50,075 shares0Common Stock, $0.01 par value per shareSEC:0001104659-20-048727:0
2 of 2 declarations
